COVID-19 clinical outcomes and nationality: results from a Nationwide registry in Kuwait.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
10 Sep 2020
Historique:
received: 19 06 2020
accepted: 01 09 2020
entrez: 11 9 2020
pubmed: 12 9 2020
medline: 15 9 2020
Statut: epublish

Résumé

In light of the COVID-19 pandemic, many have flagged racial and ethnic differences in health outcomes in western countries as an urgent global public health priority. Kuwait has a unique demographic profile with two-thirds of the population consisting of non-nationals, most of which are migrant workers. We aimed to explore whether there is a significant difference in health outcomes between non-Kuwaiti and Kuwaiti patients diagnosed with COVID-19. We used a prospective COVID-19 registry of all patients (symptomatic and asymptomatic) in Kuwait who tested positive from February 24th to April 20th, 2020, collected from Jaber Al-Ahmad Al-Sabah Hospital, the officially-designated COVID-19 healthcare facility in the country. We ran separate logistic regression models comparing non-Kuwaitis to Kuwaitis for death, intensive care unit (ICU) admission, acute respiratory distress syndrome (ARDS) and pneumonia. The first 1123 COVID-19 positive patients in Kuwait were all recruited in the study. About 26% were Kuwaitis and 73% were non-Kuwaiti. With adjustments made to age, gender, smoking and selected co-morbidities, non-Kuwaitis had two-fold increase in the odds of death or being admitted to the intensive care unit compared to Kuwaitis (OR: 2.14, 95% CI 1.12-4.32). Non-Kuwaitis had also higher odds of ARDS (OR:2.44, 95% CI 1.23-5.09) and pneumonia (OR: 2.24, 95% CI 1.27-4.12). This is the first study to report on COVID-19 outcomes between Kuwaiti and non-Kuwaiti patients. The current pandemic may have amplified the differences of health outcomes among marginalized subpopulations. A number of socioeconomic and environmental factors could explain this health disparity. More research is needed to advance the understanding of policymakers in Kuwait in order to make urgent public health interventions.

Sections du résumé

BACKGROUND BACKGROUND
In light of the COVID-19 pandemic, many have flagged racial and ethnic differences in health outcomes in western countries as an urgent global public health priority. Kuwait has a unique demographic profile with two-thirds of the population consisting of non-nationals, most of which are migrant workers. We aimed to explore whether there is a significant difference in health outcomes between non-Kuwaiti and Kuwaiti patients diagnosed with COVID-19.
METHODS METHODS
We used a prospective COVID-19 registry of all patients (symptomatic and asymptomatic) in Kuwait who tested positive from February 24th to April 20th, 2020, collected from Jaber Al-Ahmad Al-Sabah Hospital, the officially-designated COVID-19 healthcare facility in the country. We ran separate logistic regression models comparing non-Kuwaitis to Kuwaitis for death, intensive care unit (ICU) admission, acute respiratory distress syndrome (ARDS) and pneumonia.
RESULTS RESULTS
The first 1123 COVID-19 positive patients in Kuwait were all recruited in the study. About 26% were Kuwaitis and 73% were non-Kuwaiti. With adjustments made to age, gender, smoking and selected co-morbidities, non-Kuwaitis had two-fold increase in the odds of death or being admitted to the intensive care unit compared to Kuwaitis (OR: 2.14, 95% CI 1.12-4.32). Non-Kuwaitis had also higher odds of ARDS (OR:2.44, 95% CI 1.23-5.09) and pneumonia (OR: 2.24, 95% CI 1.27-4.12).
CONCLUSION CONCLUSIONS
This is the first study to report on COVID-19 outcomes between Kuwaiti and non-Kuwaiti patients. The current pandemic may have amplified the differences of health outcomes among marginalized subpopulations. A number of socioeconomic and environmental factors could explain this health disparity. More research is needed to advance the understanding of policymakers in Kuwait in order to make urgent public health interventions.

Identifiants

pubmed: 32912230
doi: 10.1186/s12889-020-09490-y
pii: 10.1186/s12889-020-09490-y
pmc: PMC7482377
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1384

Subventions

Organisme : Kuwait Foundation for the Advancement of Sciences
ID : COR-PROP-35

Références

N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Soc Sci Med. 2009 Mar;68(6):1183-90
pubmed: 19185964
Soc Sci Med. 2000 Oct;51(8):1143-61
pubmed: 11037206
J Infect. 2020 Jun;80(6):656-665
pubmed: 32283155
Lancet Respir Med. 2020 Apr;8(4):e20
pubmed: 32171067
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
J R Soc Med. 2015 Oct;108(10):406-17
pubmed: 26152675
Lancet. 2020 May 2;395(10234):1421-1422
pubmed: 32330427
J Immigr Minor Health. 2014 Feb;16(1):165-76
pubmed: 23124632
Annu Rev Public Health. 2018 Apr 1;39:351-365
pubmed: 29400993
J Cosmet Dermatol. 2020 Jul;19(7):1545-1547
pubmed: 32301221
Lancet. 2020 May 30;395(10238):1673-1676
pubmed: 32401716
Lancet Psychiatry. 2020 Apr;7(4):e20
pubmed: 32085842
Curr Epidemiol Rep. 2015 Mar;2(1):80-87
pubmed: 28133588
Environ Int. 2019 May;126:476-483
pubmed: 30844583
Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67
pubmed: 31573350
Sci Adv. 2020 Nov 4;6(45):
pubmed: 33148655
Sci Total Environ. 2020 Aug 25;732:139289
pubmed: 32438154
BMJ. 2020 Apr 20;369:m1548
pubmed: 32312785

Auteurs

Hala Hamadah (H)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Jaber Al-Ahmad Al-Sabah Hospital, Ministry of Health, Kuwait City, Kuwait.

Barrak Alahmad (B)

Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Mohammad Behbehani (M)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Sarah Al-Youha (S)

Jaber Al-Ahmad Al-Sabah Hospital, Ministry of Health, Kuwait City, Kuwait.

Sulaiman Almazeedi (S)

Jaber Al-Ahmad Al-Sabah Hospital, Ministry of Health, Kuwait City, Kuwait.

Mohannad Al-Haddad (M)

Jaber Al-Ahmad Al-Sabah Hospital, Ministry of Health, Kuwait City, Kuwait.

Mohammad H Jamal (MH)

Jaber Al-Ahmad Al-Sabah Hospital, Ministry of Health, Kuwait City, Kuwait.

Salman Al-Sabah (S)

Jaber Al-Ahmad Al-Sabah Hospital, Ministry of Health, Kuwait City, Kuwait. salman.k.alsabah@gmail.com.
Faculty of Medicine, Kuwait University, Kuwait City, Kuwait. salman.k.alsabah@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH